Content about PITTSBURGH

PITTSBURGH — GNC on Monday announced an exclusive licensing agreement with Shadow Beverages and Snacks, the producer and distributor of Ironclad Energy + Hydration and No Fear Energy drinks.

The deal is expected to push the GNC brand name beyond its retail base and partnership with Rite Aid in the drug channel. Under the terms of the licensing agreement, Shadow Beverages and Snacks will produce a line of ready-to-drink products that will be marketed under the GNC brand.

PITTSBURGH — Drug maker Mylan has launched a generic treatment for muscle spasms, the company said Friday.

Mylan announced the launch of cyclobenzaprine hydrochloride, a once-daily muscle relaxant, in the 15-mg and 30-mg strengths. The drug is a generic version of Cephalon’s Amrix, which had sales of about $125 million during the 12-month period ended in March, according to IMS Health.

PITTSBURGH — Giant Eagle is celebrating its locally and regionally grown produce with a new video on its website.

The retailer said that it is taking several steps to educate consumers on which fruits and vegetables are at their peak season throughout the year, and is further relaying this message through its video, which can be viewed on the company's website.

You can’t be all things to all people, but you can be all things to one person. That’s the opportunity Giant Eagle is grabbing with the number of ways the Pittsburgh food-and-pharmacy retailer interacts with patients. 


“Our goal is to help those within our communities live healthier, longer lives,” Dan Donovan, Giant Eagle spokesman, told Drug Store News. “We look to do this in a number of ways … [through] initiatives, such as our health and beauty care business, in-store retail health clinics and our group of skilled dietitians.”


PITTSBURGH — Mylan has launched a generic drug for treating herpes, the company said Wednesday.

Mylan announced the launch of famciclovir tablets in the 125-mg, 250-mg and 500-mg strengths. The drug is a generic version of Novartis’ Famvir.

Branded and generic versions of the drug had sales of $196 million in 2010, according to IMS Health.

PITTSBURGH — Mylan subsidiary Bioniche Pharma has launched an injectable treatment for a rare metabolic disorder, Mylan said Tuesday.

Mylan announced the launch of octreotide acetate injection in prefilled syringes, a generic version of Novartis’ Sandostatin, used to treat the disorder acromegaly and suppress or inhibit severe diarrhea related to certain tumors. Acromegaly results from excess growth hormone produced in the pituitary gland, causing fatigue and weakness, body odor and carpal tunnel syndrome.

PITTSBURGH — The Food and Drug Administration has approved a generic drug made by Mylan that reduces pressure in the eye, Mylan said Monday.

Mylan announced the approval of latanoprost ophthalmic solution in the 0.005% strength. The drug is a generic version of Xalatan, made by Pharmacia and Upjohn, now part of Pfizer.

Various versions of the drug had sales of around $711 million in 2010, according to IMS Health.

PITTSBURGH — GNC is ready to pull the trigger on a long-anticipated initial public offering this Friday, according to several published reports.

It’ll be the third bite of the IPO apple for the Pittsburgh-based specialty chain. But if any time is a right time, that time is now, the company suggested in its prospectus, pointing to the graying of the baby boomer, coupled with increased pursuit of healthier lifestyles, which makes for a strong investment proposition for an already-established specialty channel retailer.

NEW YORK — A new report released this week unveiled the top go-to markets for retailers that are looking to boost their national presence.

In the ChainLinks/Terranomics' 2011 U.S. national retail report, the healthiest retail market in the nation was Washington, D.C., followed by San Francisco; New York; Boston; San Diego; San Jose/South Bay, Calif.; Baltimore; Philadelphia; Seattle and Pittsburgh.

PITTSBURGH — Giant Eagle on Thursday received the American Diabetes Association's prestigious Chairman's Citation Award, which recognizes the accomplishments of individuals, corporations, institutions and organizations who have demonstrated dedication and commitment, and have had a positive impact in advancing the mission of the ADA.

PITTSBURGH — A subsidiary of Mylan has won approval to sell a generic drug for HIV and AIDS in developing countries under the President’s Emergency Plan for AIDS Relief.

Mylan announced Thursday that Matrix Labs won Food and Drug Administration approval for zidovudine tablets in the 100-mg strength. The drug is a generic version of ViiV Healthcare’s Retrovir, an antiretroviral sold as a water-dispersible tablet. The drug is designed to treat HIV and AIDS in children and prevent transmission of the virus from pregnant mothers to their children.